436 related articles for article (PubMed ID: 30530893)
1. The role of neurovascular unit damage in the occurrence and development of Alzheimer's disease.
Liu X; Hou D; Lin F; Luo J; Xie J; Wang Y; Tian Y
Rev Neurosci; 2019 Jul; 30(5):477-484. PubMed ID: 30530893
[TBL] [Abstract][Full Text] [Related]
2. Locus Coeruleus and neurovascular unit: From its role in physiology to its potential role in Alzheimer's disease pathogenesis.
Giorgi FS; Galgani A; Puglisi-Allegra S; Limanaqi F; Busceti CL; Fornai F
J Neurosci Res; 2020 Dec; 98(12):2406-2434. PubMed ID: 32875628
[TBL] [Abstract][Full Text] [Related]
3. Interactions between glial cells and the blood-brain barrier and their role in Alzheimer's disease.
Zhao M; Jiang XF; Zhang HQ; Sun JH; Pei H; Ma LN; Cao Y; Li H
Ageing Res Rev; 2021 Dec; 72():101483. PubMed ID: 34610479
[TBL] [Abstract][Full Text] [Related]
4. Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer's disease.
Nelson AR; Sweeney MD; Sagare AP; Zlokovic BV
Biochim Biophys Acta; 2016 May; 1862(5):887-900. PubMed ID: 26705676
[TBL] [Abstract][Full Text] [Related]
5. Strong Impact of Chronic Cerebral Hypoperfusion on Neurovascular Unit, Cerebrovascular Remodeling, and Neurovascular Trophic Coupling in Alzheimer's Disease Model Mouse.
Shang J; Yamashita T; Zhai Y; Nakano Y; Morihara R; Fukui Y; Hishikawa N; Ohta Y; Abe K
J Alzheimers Dis; 2016 Mar; 52(1):113-26. PubMed ID: 27060955
[TBL] [Abstract][Full Text] [Related]
6. Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer's Disease.
Yamazaki Y; Kanekiyo T
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28902142
[TBL] [Abstract][Full Text] [Related]
7. The blood-brain barrier in Alzheimer's disease.
Zenaro E; Piacentino G; Constantin G
Neurobiol Dis; 2017 Nov; 107():41-56. PubMed ID: 27425887
[TBL] [Abstract][Full Text] [Related]
8. [Alzheimer's disease as neurodegenerative disorder].
Zabłocka A
Postepy Hig Med Dosw (Online); 2006; 60():209-16. PubMed ID: 16641890
[TBL] [Abstract][Full Text] [Related]
9. Twendee X Ameliorates Phosphorylated Tau, α-Synuclein and Neurovascular Dysfunction in Alzheimer's Disease Transgenic Mice With Chronic Cerebral Hypoperfusion.
Liu X; Yamashita T; Shang J; Shi X; Morihara R; Huang Y; Sato K; Takemoto M; Hishikawa N; Ohta Y; Abe K
J Stroke Cerebrovasc Dis; 2019 Oct; 28(10):104310. PubMed ID: 31383622
[TBL] [Abstract][Full Text] [Related]
10. The Neurovascular Unit Dysfunction in Alzheimer's Disease.
Soto-Rojas LO; Pacheco-Herrero M; Martínez-Gómez PA; Campa-Córdoba BB; Apátiga-Pérez R; Villegas-Rojas MM; Harrington CR; de la Cruz F; Garcés-Ramírez L; Luna-Muñoz J
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670754
[TBL] [Abstract][Full Text] [Related]
11. Neurovascular defects and faulty amyloid-β vascular clearance in Alzheimer's disease.
Sagare AP; Bell RD; Zlokovic BV
J Alzheimers Dis; 2013; 33 Suppl 1(0 1):S87-100. PubMed ID: 22751174
[TBL] [Abstract][Full Text] [Related]
12. Linking Cerebrovascular Dysfunction to Age-Related Hearing Loss and Alzheimer's Disease-Are Systemic Approaches for Diagnosis and Therapy Required?
Förster CY; Shityakov S; Scheper V; Lenarz T
Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36421731
[TBL] [Abstract][Full Text] [Related]
13. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
14. The role of perivascular innervation and neurally mediated vasoreactivity in the pathophysiology of Alzheimer's disease.
Nizari S; Romero IA; Hawkes CA
Clin Sci (Lond); 2017 Jun; 131(12):1207-1214. PubMed ID: 28566449
[TBL] [Abstract][Full Text] [Related]
15. The pericyte: a forgotten cell type with important implications for Alzheimer's disease?
Winkler EA; Sagare AP; Zlokovic BV
Brain Pathol; 2014 Jul; 24(4):371-86. PubMed ID: 24946075
[TBL] [Abstract][Full Text] [Related]
16. Impact of Tau on Neurovascular Pathology in Alzheimer's Disease.
Canepa E; Fossati S
Front Neurol; 2020; 11():573324. PubMed ID: 33488493
[TBL] [Abstract][Full Text] [Related]
17. Regulation of tau phosphorylation in Alzheimer's disease.
Lee VM
Ann N Y Acad Sci; 1996 Jan; 777():107-13. PubMed ID: 8624072
[TBL] [Abstract][Full Text] [Related]
18. Spatiotemporal activation of the C/EBPβ/δ-secretase axis regulates the pathogenesis of Alzheimer's disease.
Wang H; Liu X; Chen S; Ye K
Proc Natl Acad Sci U S A; 2018 Dec; 115(52):E12427-E12434. PubMed ID: 30530690
[TBL] [Abstract][Full Text] [Related]
19. The blood brain barrier in Alzheimer's disease.
Chakraborty A; de Wit NM; van der Flier WM; de Vries HE
Vascul Pharmacol; 2017 Feb; 89():12-18. PubMed ID: 27894893
[TBL] [Abstract][Full Text] [Related]
20. Neurovascular unit impairment in early Alzheimer's disease measured with magnetic resonance imaging.
van de Haar HJ; Jansen JFA; van Osch MJP; van Buchem MA; Muller M; Wong SM; Hofman PAM; Burgmans S; Verhey FRJ; Backes WH
Neurobiol Aging; 2016 Sep; 45():190-196. PubMed ID: 27459939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
